Abstract: Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an important inhibitor of T -lymphocyte response. Polymorphisms in the CTLA-4 gene have been reported to be associated with numerous autoimmune diseases. The aim of this study was to determine whether polymorphisms of CTLA-4 exon 1 (+49) genes are associated with susceptibility and clinicolaboratory findings of primary biliary cirrhosis (PBC) in the J apanease population. Blood samples were obtained from 45 patients (6 men and 39 women, aged 23-56 years) with PBC and 73 healthy controls (48 men and 25 women, aged 22-72 years). CTLA-4 ex on 1 (+49) polymorphism was defined using a polymerase chain reaction-restriction fragment length polymorphism with Bst71I restriction enzyme. The genotype frequencies of AI A, A/G, and GIG in 45 patients with PBC were 11% (5 patients), 44% (20 patients), and 44% (20 patients), respectively. There was no significant difference between frequencies in PBC patients and healthy controls. PBC patients with GIG genotype had significantly higher serum levels of ALT, GGT, and IgM than those in patients with AI A or A/G genotype. In conclusion, CTLA -4 gene polymorphisms are not associated with susceptibility of PBC in Japan; however, GIG genotype may be associated with liver damage.
INTRODUCTION
Primary biliary cirrhosis (PBC) is an idiopathic liver disease characterized by progressive destruction of intrahepatic bile ducts and possibly caused by autoimmune reactions l ). It is generally believed that cytotoxic T cells in the biliary epithelial layer play an important role in biliary epithelial destruction 2 ) .
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is involved in the regulation of T cells and its antigen is only expressed on activated T cells. which binds to CD80 molecules on antigen-presenting cells 3 ,4) . This binding delivers negative signals to T cells that affect T cell proliferation, cytokine production, and immune responses. The CTLA-4 gene is located on chromosome 2q33 and three CTLA-4 gene polymorphisms in exon 1 (adenine or guanine at position) and in promoter -318, and a microsatellite (AT) n marker at position 642 of the 3' -untranslated region of exon 3 5 ,6 ). CTLA-4 gene polymorphisms have been shown to be associated with type 1 diabetes 7 ), Graves' disease), celiac diseaseS), and Addison's disease 9 ) . CTLA-4 exon 1 (+49) genes G allele and GIG genotype are reported to confer genetic susceptibility to these diseases. In addition, CTLA-4 (+49) genes are reported that GG genotype is associated with more severe cell dysfunction in type 1 diabetes lO ) .
In this study, we investigated whether polymorphisms of CTLA-4 exon 1 (+49) genes are associated with susceptibility and clinicolaboratory findings of PBC in the Japanese population.
MATERIALS AND METHODS

Patients
Blood samples were obtained from 45 patients (6 men and 39 women, aged 23-56 years) with PBC and 73 healthy controls (48 men and 25 women, aged 22-72 years) . PBC was diagnosed by either histology of liver biopsy specimens or clinical findings of anti-mitochondrial antibodies (AMA) and cholestatic dysfunction of the liver followed by jaundice or puritus, based on 'Criteria for diagnosis of PBC in Japan' by the Study Group for Autoimmune Hepatitis, a subdivision of the Research Group for Intractable Hepatitis sponsored by the Ministry of Health and Welfare of Japan ll ). Blood was collected in EDTA tubes and DNA from peripheral blood mononuclear cells was isolated using the Genomic DNA purification kit (Gentra systems, Minnesota, USA).
In sera from patients with PBC, AMA was simultaneously detected by indirect immunofluorescence using frozen sections of a rat kidney. All subjects gave written informed consent to participate in this study.
Polymorphism typing of CTLA-4 exon 1 (+49)
CTLA-4 exon 1 (+49) polymorphism was defined using a polymerase chain 
)
Briefly, PCR was carried out using a forwa rd primer 5' -CCACGGCTTCCTTTCTCGTA-3' and a reverse primer 5' -AGTCTCACTCACCTTTGCAG -3' . Using a Park in El mer therma l cycler, samples were subjected to initial denaturation for 2 min at 95°C, 40 cycles fo r 30s at 94°C for denaturing, 45s at 50T for an nealing a nd 30s at 72°C fo r ex tension. A 328-bp fragment conta ining + 49 A/ G polymorph ism in exo n 1 of CTLA-4 was amplified. The substitution created a Bst71I restriction site in G a llele. Amplified products were incubated at 65°C for 2 h using 2 U of Bst71I per reaction. Digested products were electrophoresed on a 2.0 % agarose gel. Digested G a ll ele yielded fragments of 244 bp and 84 bp, and a n a ll e le yielded a 328-bp fragment (Fig ure 1) .
Statistical analysis
Results are expressed as means ± SD. Statistica l ana lysis of the data was performed using the chi -sq ua re test, two -ta il ed We lch's [-test a nd Kruska l-Wa llis ra nk test. Differences with a P value < 0.05 were considered sig nificant.
RESULTS
GenotyjJe frequencies
The genotype frequencies of A / A, A/ G, and G/ G at exon 1 ( + 49) on CTLA-4 gene in 45 patients with PBC were 11 % (5 patients) , 44 % (20 patients), and 44% (20 patients), respectively, as shown in Table 1 . Those in 73 healthy controls were 19%14), 45%33), and 36%26), respectively. There was no significant difference between frequencies in the two.
Genotype frequency and clinicolaboratory findings
As shown in Table 2 , PBC patients with GIG genotype at ex on 1 (+49) on CTLA-4 gene had significantly higher in serum levels of ALT, GGT, and IgM than those in patients with AI A or AIG genotype. However, there were no significant differences in other clinicolaboratory findings according to the three genotypic variations. In histological stage, there were no significant differences.
DISCUSSION
There have been some in which CTLA-4 gene polymorphisms in patients with PBC were assessed 12 -15 ). Studies conducted in the UK, USA and China have shown that CTLA-4 gene polymorphisms are associated with susceptibility of PB0 2 ,14,15). However, a study carried out in Brazil showed no association 13 ). In the present study, there were no significant differences between PBC patients and healthy controls in the genotype and allele frequencies at exon 1 (+49) on the CTLA-4 gene. It is also necessary to consider the difference in race. However, a study in China showed that allelic variation at the +49 site of CTLA-4 exon 1 was significantly associated with PBC and that the frequency of G alleles was increased in patients with PBC compared with that in controls14). In our study, G allelic variations were found in 67% of the PBC patients and 58% of the controls.
There has been no report to date of a significant association between CTLA-4 gene polymorphisms and clinicolaboratory findings in patients with PBe. In this study, we showed that PBC patients with GIG genotype at exon 1 (+49) on the CTLA-4 gene had significantly higher serum levels of ALT, GGT, and IgM than those in patients with AI A or A/G genotype. The CTLA-4 molecule is an important inhibitor of T -lymphocyte response. T cell respones would certainly participate in the pathogenesis of PBC, as judged by histochemical staining of tissue samples, and by analyzing T cell lines that proliferate in the presence of putative mitochondrial autoantigens. Kouki et at. reported that the inhibitory effect of CTLA-4 on T cells was less potent in cells from subjects with (+49) GIG than AI A alleles, and suggested that this particular polymorphism was the actual diseaseassociated allele 16 ). Thus, PBC patients with GIG genotype at exon 1 (+49) may be more strongly injured by T cells. In this study, there was no significant difference in histological stage and CTLA-4 genotype. Serial clinical analysis is needed in order to evaluate whether GIG genotype at ex on 1 (+49) is associated to development of PBe. Polymorphisms in the CTLA-4 gene have been reported to be associated with numerous autoimmune diseases; however, other diseases such as Graves' diseasel7) and idiopathic hypoparathyroidism 18 ) showed no significant association in clinicolaboratory findings. Thus, examination of clinical usefulness is also needed in future.
There have been many reports of other immunorelated gene polymorphisms in patients with PBC such as polymorphisms in mannose-binding lectin 19 ) , cytokeratin-19 pseudogene 20 ), interleukin-10 promotor gene 2 1), endothelial nitric oxide synthesis gene 22 ), and toll-like receptor-9 gene 23 ). All of those studies showed an association with susceptibility of PBC, but analysis of single gene polymorphism induces limit. We think that analysis by genetic assembly becomes necessary instead of by genetic single analysis in order to make clear genetic association in patients with PBe.
